FDA Drug Recalls

Recalls / Class III

Class IIID-1063-2016

Product

Sirolimus Tablets, 1 mg, 100-count bottle, Rx only, Manufactured by: Dr. Reddy's Laboratories Limited, Visakhapatnam - 5300046 India, NDC 55111-653-01

Brand name
Sirolimus
Generic name
Sirolimus
Active ingredient
Sirolimus
Route
Oral
NDCs
55111-653, 55111-654
FDA application
ANDA201578
Affected lot / code info
Lot # H400044, H400045 , Exp 07/16; H400048, Exp 08/16; H400055, Exp 10/16; H400070, H400071, H400073 and H400074, Exp 11/16

Why it was recalled

Failed impurities/degradation: out of specification result for impurity secorapamycin.

Recalling firm

Firm
Dr. Reddy's Laboratories, Inc.
Manufacturer
Dr. Reddy's Laboratories Limited
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
107 College Rd E, N/A, Princeton, New Jersey 08540-6623

Distribution

Quantity
9,330 bottles
Distribution pattern
Nationwide

Timeline

Recall initiated
2016-06-03
FDA classified
2016-07-05
Posted by FDA
2016-07-13
Terminated
2017-04-07
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1063-2016. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: Sirolimus · FDA Drug Recalls